STOCK TITAN

POSITRON CORP - $POSC STOCK NEWS

Welcome to our dedicated page for POSITRON news (Ticker: $POSC), a resource for investors and traders seeking the latest updates and insights on POSITRON stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect POSITRON's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of POSITRON's position in the market.

Rhea-AI Summary
Positron Corporation (POSC) welcomes a prominent cardiovascular practice in Pennsylvania as a new customer utilizing the Attrius PET System and services. The company offers a dedicated PET scanner optimized for nuclear cardiology, providing robust high-resolution images and accurate measurements of absolute blood flow. Positron's Lease to Own Program offers a complete package of the Attrius PET System and full scope Clinical & Technical Services for one monthly price for five years, with zero upfront capex expense. The company expects to enter additional lease to own/services agreements with other interested parties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.91%
Tags
none
-
Rhea-AI Summary
Positron welcomes a prominent cardiovascular practice in California as a new customer utilizing Positron's Attrius PET System and services. The company anticipates entering five more Attrius Lease to Own/Services agreements by year's end. Positron's PET Lease to Own & Services Program offers a complete package with zero upfront capex expense, providing a viable operational model for nuclear imaging PET practices. The company aims to provide hospitals and private practices with the best technology, services, and solutions to meet customer needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Positron Corporation to begin clinical study of Affinity PET-CT imaging device with Ochsner Clinic Foundation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
Rhea-AI Summary
Positron Corporation (POSC) Announces Business Cooperative Partnership and Acquisition of PET Imaging Systems Inventory
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.64%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
POSITRON CORP

OTC:POSC

POSC Rankings

POSC Stock Data

28.67M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Houston

About POSC

positron corporation is a nuclear medicine healthcare company specializing in the field of cardiac positron emission tomography (pet) imaging. focused exclusively on supporting cardiac pet for over 30 years, positron is committed to minimizing the barriers of entry to make this superior modality more accessible to clinicians and patients everywhere. recognized as the gold standard in diagnostic nuclear imaging, cardiac pet is the most effective method in nuclear cardiology for detecting coronary artery disease. positron’s attrius® offers the latest in cardiac pet technology and is the only choice when looking for a new dedicated pet system. optimized for mpi, the attrius provides excellent sensitivity with minimal radiation exposure, when compared to spect, and is capable of performing routine quantitative measurements. the attrius system enables healthcare providers to more accurately diagnose heart disease, improve patient outcomes, and practice cost effective medicine. pet is the pr